Gilead says trial of remdesivir as COVID-19 treatment met main goal https://t.co/mgdu9kEc1C— MarketWatch (@MarketWatch) April 29, 2020
Gilead says trial of remdesivir as COVID-19 treatment met main goal https://t.co/mgdu9kEc1C